$69.68
-6.21-8.18%
Last update: Nov 13, 10:46 AM
Tempus AI Inc
TEMNASDAQ
Tempus AI rose 11.7% from $67.94 to $75.89, behind the S&P 500's +12.7%. Its worst day was Oct 6 (−13.8%), and its low came Jul 29 at $41.55.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.04 beat the $-0.14 estimate on $367.2M revenue (est. $364.8M); FY revenue guidance of $1.6B against the $1.6B consensus.
−7.3% · S&P 500 +0.8%
Story events cover the past 12 months · Times ET
Tempus AI shares rose 13.9%, while the S&P 500 rose 0.8%.
+13.9% · S&P 500 +0.8%
EPS of $-0.13 beat the $-0.25 estimate on $348.1M revenue (est. $345.5M); FY revenue guidance of $1.6B–$1.6B against the $1.6B consensus.
−1.1% · S&P 500 +1.4%
EPS of $-0.04 beat the $-0.20 estimate on $382.5M revenue (est. $380.2M); FY revenue guidance of $1.6B–$1.6B against the $1.6B consensus.
−0.9% · S&P 500 +0.7%
Shares of Tempus AI are surging Wednesday morning as traders connected the dots between a landmark clinical trial win and Tempus’s recent multi-billion dollar acquisition deal.
+24.1%, the year's best day, on 23M shares, the year's heaviest volume · S&P 500 +0.2%
Tempus AI shares rose 14.8%, while the S&P 500 rose 0.9%.
+14.8% · S&P 500 +0.9%
Tempus AI closed at its highest level of the year, 25.2% above where the year started.
+0.1% · S&P 500 −0.7%
Tempus AI shares fell 13.8%, while the S&P 500 rose 0.5%.
−13.8%, the year's worst day · S&P 500 +0.5%
EPS of $0.07 beat the $-0.13 estimate on $411.5M revenue (est. $409.7M); FY revenue guidance of $1.6B–$1.6B against the $1.6B consensus.
+8.7% · S&P 500 −0.5%
Where it ended: a close of $75.89 on Nov 12, 2026. Up next: Q4 2026 earnings on Feb 23, 2027 (EPS est. $-0.01, revenue est. $459.0M).
Nothing in the past 12 months.
All TEM dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TEM and SPY from Benzinga historical bars. Not investment advice.
